Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02571660Phase 3Unknown
Phase 3, randomised trial of vitamin d in asthma (2 arms), sponsored by Hospital General Naval de Alta Especialidad - Escuela Médico Naval. Primary endpoint: Free lapse of asthma exacerbation at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02571660.